MARKET

SONN

SONN

Sonnet BioTherapeutics Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.5869
-0.0037
-0.63%
After Hours: 0.5850 -0.0019 -0.32% 19:59 09/21 EDT
OPEN
0.5900
PREV CLOSE
0.5906
HIGH
0.5970
LOW
0.5835
VOLUME
2.51M
TURNOVER
--
52 WEEK HIGH
3.415
52 WEEK LOW
0.5508
MARKET CAP
34.13M
P/E (TTM)
-0.1409
1D
5D
1M
3M
1Y
5Y
38 Stocks Moving In Wednesday's Mid-Day Session
Gainers Indaptus Therapeutics, Inc. (NASDAQ: INDP) shares jumped 177.2% to $19.60 after the company announced the United States Patent and Trademark Office has issued a notice of allowance for claims related to the company's platform technology.
Benzinga · 6d ago
BTIG Initiates Coverage On Sonnet BioTherapeutics with Buy Rating, Announces Price Target of $5
BTIG initiates coverage on Sonnet BioTherapeutics (NASDAQ:SONN) with a Buy rating and announces Price Target of $5.
Benzinga · 6d ago
--BTIG Starts Sonnet BioTherapeutics Holdings at Buy with $5 Price Target
MT Newswires · 6d ago
Company News for Sep 1, 2021
Zacks.com · 09/01 13:41
Mid-Afternoon Market Update: Spok Holdings Surges On Takeover Offer; Sequential Brands Shares Slide
Toward the end of trading Tuesday, the Dow traded down 0.09% to 35,366.93 while the NASDAQ fell 0.02% to 15,263.43. The S&P also fell, dropping 0.11% to 4,523.94.
Benzinga · 08/31 18:26
Mid-Day Market Update: Zoom Shares Drop After Q2 Results; AC Immune Shares Surge
Midway through trading Tuesday, the Dow traded down 0.01% to 35,396.15 while the NASDAQ fell 0.25% to 15,227.25. The S&P also fell, dropping 0.09% to 4,524.67.
Benzinga · 08/31 16:13
33 Stocks Moving In Tuesday's Mid-Day Session
Gainers
Benzinga · 08/31 16:05
Why Sonnet BioTherapeutics Stock Is Trading Higher Today
Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) is trading significantly higher Tuesday after the company announced the successful completion of the discovery phase for its next preclinical pipeline candidate, SON-1410.
Benzinga · 08/31 13:57
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SONN. Analyze the recent business situations of Sonnet BioTherapeutics Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SONN stock price target is 6.50 with a high estimate of 8.00 and a low estimate of 5.00.
EPS
Institutional Holdings
Institutions: 25
Institutional Holdings: 1.31M
% Owned: 2.25%
Shares Outstanding: 58.15M
TypeInstitutionsShares
Increased
3
572.13K
New
3
63.69K
Decreased
1
72.28K
Sold Out
7
231.13K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.40%
Pharmaceuticals & Medical Research
+0.74%
Key Executives
Chairman/President/Chief Executive Officer/Director
Pankaj Mohan
Chief Financial Officer/Treasurer/Secretary
John Cross
Corporate Executive
Richard Adams
Chief Operating Officer
Mark Roberson
Chief Technology Officer
Susan Dexter
Chief Scientific Officer
John Cini
Other
Manuel Dafonseca
Other
Richard Kenney
Other
Terence Rugg
Director
Nailesh Bhatt
Director
Albert Dyrness
Director
Donald Griffith
Director
Raghu Rao
No Data
  • All
  • Financials
  • Insiders
More
About SONN
Sonnet Biotherapeutics Holdings Inc, formerly Chanticleer Holdings, Inc., an oncology-focused biotechnology company. The Company is developing targeted biologic drugs with enhanced single or bispecific mechanisms.

Webull offers kinds of Sonnet Biotherapeutics Holdings Inc stock information, including NASDAQ:SONN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SONN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SONN stock methods without spending real money on the virtual paper trading platform.